Cargando…

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors

BACKGROUND: We aimed to describe the most frequently prescribed initial antiretroviral therapy (ART) regimens in recent years in HIV-positive persons in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) and to investigate factors associated with the choice of each regimen. METHODS: We anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alejos, Belén, Suárez-García, Inés, Bisbal, Otilia, Iribarren, José Antonio, Asensi, Víctor, Górgolas, Miguel, Muga, Roberto, Moreno, Santiago, Jarrín, Inma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709901/ https://www.ncbi.nlm.nih.gov/pubmed/31449566 http://dx.doi.org/10.1371/journal.pone.0221598

Ejemplares similares

Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection
por: Alejos, Belén, et al.
Publicado: (2016)

All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997–2010
por: Hernando, Victoria, et al.
Publicado: (2013)

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort
por: Suarez-García, Ines, et al.
Publicado: (2021)

Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)
por: Blanco, Jose-Ramon, et al.
Publicado: (2020)

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
por: Suárez-García, Inés, et al.
Publicado: (2023)

Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single‐tablet regimen in a multicentre cohort in Spain
por: Suárez‐García, Inés, et al.
Publicado: (2021)

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
por: Zhu, Jielin, et al.
Publicado: (2019)

Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004–2018
por: Domínguez-Domínguez, Lourdes, et al.
Publicado: (2022)

Prototype foamy virus integrase is promiscuous for target choice
por: Mackler, R.M., et al.
Publicado: (2018)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004–2018
por: Rava, Marta, et al.
Publicado: (2021)

Multiple choices for HIV therapy with integrase strand transfer inhibitors
por: Raffi, Francois, et al.
Publicado: (2012)

Initiation of antiretroviral therapy with integrase strand-transfer inhibitor-based regimens and reduction of the risk of horizontal transmission of HIV-1
por: Berenguer, Juan, et al.
Publicado: (2019)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure
por: van Hal, Sebastiaan J, et al.
Publicado: (2009)

Timeliness of antiretroviral therapy initiation in the era before universal treatment
por: Bogdanić, Nikolina, et al.
Publicado: (2021)

Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
por: Estrada, Vicente, et al.
Publicado: (2022)

Temporal Trends and Geographic Variability in the Prescription of Antiretroviral Treatments in People Living with HIV in Spain, 2004–2020
por: Ruiz-Algueró, Marta, et al.
Publicado: (2022)

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study
por: Suárez-García, Inés, et al.
Publicado: (2020)

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
por: Vogel, Martin, et al.
Publicado: (2009)

The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy
por: Fernandes, Sara Rodrigues, et al.
Publicado: (2023)

Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States
por: Rebeiro, Peter F., et al.
Publicado: (2023)

A targeted DNA substrate mechanism for the inhibition of HIV‐1 integrase by inhibitors with antiretroviral activity
por: Ammar, Farah F., et al.
Publicado: (2016)

Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy
por: Vakili, Sarah, et al.
Publicado: (2022)

Antiretroviral Therapy (ART) Use, Human Immunodeficiency Virus (HIV)-1 RNA Suppression, and Medical Causes of Hospitalization Among HIV-Infected Intravenous Drug Users in the Late ART Era
por: Vallecillo, Gabriel, et al.
Publicado: (2014)

Integrase and integration: biochemical activities of HIV-1 integrase
por: Delelis, Olivier, et al.
Publicado: (2008)

Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection
por: Prats, Anna, et al.
Publicado: (2021)

Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
por: Rhee, Soo-Yon, et al.
Publicado: (2008)

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2012)

Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy
por: McCausland, Marie R., et al.
Publicado: (2015)

334. Weight Change Associated with Antiretroviral Therapy Switch to Integrase Strand Transfer Inhibitor-Based Regimens
por: Saber, Saghar, et al.
Publicado: (2019)

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment
por: Pyngottu, Ashima, et al.
Publicado: (2020)

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy
por: Surial, Bernard, et al.
Publicado: (2023)

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy
por: Wijting, Ingeborg E.A., et al.
Publicado: (2019)

Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV
por: Muccini, Camilla, et al.
Publicado: (2023)

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial
por: Serrano-Villar, Sergio, et al.
Publicado: (2016)

Resistance to Integrase Inhibitors
por: Métifiot, Mathieu, et al.
Publicado: (2010)

Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
por: Hutapea, Hotma Martogi Lorensi, et al.
Publicado: (2018)

Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals
por: Chalouni, Mathieu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_udcsn3an8e4l5q6m6gbapdulu3